The estimated Net Worth of Michael James Mc Clellan is at least 290 千$ dollars as of 5 November 2019. Michael Clellan owns over 695 units of Teva- Pharmaceutical Industries stock worth over 289,874$ and over the last 7 years Michael sold TEVA stock worth over 0$.
Michael has made over 2 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. Most recently Michael exercised 695 units of TEVA stock worth 12,482$ on 5 November 2019.
The largest trade Michael's ever made was exercising 4,091 units of Teva- Pharmaceutical Industries stock on 18 September 2019 worth over 73,474$. On average, Michael trades about 532 units every 5 days since 2018. As of 5 November 2019 Michael still owns at least 16,140 units of Teva- Pharmaceutical Industries stock.
You can see the complete history of Michael Clellan stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 5 BASEL STREET, PETACH TIKVA, L3, 4951033.
Over the last 7 years, insiders at Teva- Pharmaceutical Industries have traded over 31,332,399$ worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth 16,473,820$ . The most active insiders traders include Sol J Barer、Tal Zvi Zaks、Roberto Mignone. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 9 days with the average trade being worth of 636,538$. The most recent stock trade was executed by Varda Shalev on 2 September 2024, trading 12,872 units of TEVA stock currently worth 231,181$.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: